




🏆 Maureen Mork from @UTMDAnderson was not only the very deserving recipient of the 2026 Dennis J. Ahnen Outstanding Service Award at #CGAIGC26, but also delivered an insightful presentation on an important topic, "Novel Approaches to Genetic Testing." Ms Mork shared insights into the ongoing challenge of low cascade genetic testing uptake among at-risk relatives and explored potential strategies to improve participation. 🔹 Innovative approaches include patient navigation, reducing financial barriers, and at-home genetic testing. 🔹 No single intervention has consistently achieved the desired results, highlighting the need for creative, multimodal approaches to improve testing uptake. 🎥 Watch this short interview 👇to hear Ms Mork's key takeaways and what they mean for the multidisciplinary #hereditarygicancer care team. #CascadeTesting #GeneticCounseling

🎥 Does AI-assisted colonoscopy improve lesion detection in patients with #LynchSsyndrome? At #CGAIGC26, @RHuneburg from University Hospital Bonn, Germany, shares findings from the CADLY-2 trial, published in The Lancet Gastroenterology & Hepatology Watch this short video 👇 to hear the key findings and their implications for Lynch syndrome surveillance. #hereditarygicancer

📣We're excited to kick off #PancreaticCancerAwarenessMonth & sharing exciting advances in pancreatic cancer treatment! At #CGAIGC26, Dr. Lindsay Davis, a medical oncologist from the @CUCancerCenter highlights emerging treatment options, including PARP inhibitors, immunotherapy, & promising new KRAS-targeted therapies. With KRAS mutations found in approximately 93% of pancreatic cancers, these developments offer new hope for more personalized treatment approaches & improved patient outcomes. 📽️Watch this short sound bite 👇 to hear Dr. Davis share the latest developments & what they could mean for patients!

🔬 5 presenters. 5 research perspectives. One shared goal: improving Lynch syndrome care. Discover the research featured in the CCARE Lynch Syndrome Poster Walk at #CGAIGC26! 📌 Meet the presenters and explore their work: 🔹 Guillermo Alberto Clinical and Molecular Characterization of Lynch Syndrome: Experience from an Argentinian Specialized Oncology Center 🔹 Alessandro Mannucci Impact of Cecal Retroflexion on Adenoma Detection for Lynch Syndrome Surveillance Colonoscopy 🔹 Devang Namjoshi How Are Patients with Lynch Syndrome (LS) Informed About Aspirin (ASA) Chemoprevention by Genetic Counselors (GCS), and What Factors Influence Communication Behaviors? 🔹 Desha Perera Downstream Uptake of Cancer Risk Management Among Lynch Syndrome Patients 🔹 Drew Pitter Building a Lynch Syndrome Specific Psychosocial Support Program: Practical Lessons from a Psychologist Led Group Model 📅 November 2 | 3:05 – 3:35 PM 🔗 Explore the scientific program: bit.ly/3TZtxPj

A great visual reminder from @HHampel1 🗳️If you are attending #CGAIGC26 in Denver, CO, November 2–4, 2026 and planning to vote in the upcoming elections, don’t forget to make arrangements before heading to Denver! Many states offer early voting or mail-in voting options, so be sure to check what’s available in your state and plan ahead. We look forward to seeing you in Denver!
@CGAIGC friends - Please remember to vote early this week since we will be in Denver on Election Day.

How are advances in treatment, prevention, and surgical care changing the management of polyposis syndromes? At #CGAIGC26, Dr. Leah Biller, Dr. Jeongyoon Moon, and Dr. Ajay Bansal will explore evolving approaches to polyposis care, from therapy-associated polyposis and functional outcomes following colorectal surgery to the latest evidence in chemoprevention. 🔗 Learn more about our speakers and their presentations: Dr. Leah Biller: bit.ly/4i9BUkH Dr. Jeongyoon Moon: bit.ly/48mF3Yx Dr. Ajay Bansal: bit.ly/4iiaJ6d 📅 November 4 | 10:45 AM – 12:15 PM

1/ Welcome to the #CGAIGCJC Tweetorial on “Shared inheritance reveals landscape of somatic and germline cancer risk in TP53” MacGregor et al, by our Communications Committee member @annalstrang ➡️Published in American Journal of Human Genetics 👉pubmed.ncbi.nlm.nih.gov/4260… 🧵 #HereditaryGICancer

How can hereditary cancer care become more accessible, inclusive, and responsive to the needs of different patient populations? At #CGAIGC26, Session VIII: Care Delivery will bring together experts to explore approaches to improving access to genetic services, from supporting patients with neurodivergence to adapting care in resource-limited settings and advancing genetic counseling and testing in Chile. Meet the speakers who will share their insights on making hereditary cancer care more equitable and accessible: Melissa Levin: bit.ly/4yC4W1g Alanna Horowitz: bit.ly/4i0do5w Dr. Steven Schuetz: bit.ly/4zNAouG María José Mullins: bit.ly/4yMrEnK 📅 Wednesday, November 4 | 9:00–10:30 AM Join the conversation in Denver!

How can we bridge the gap between advances in cancer genetics and their implementation in everyday clinical practice? At #CGAIGC26, we're pleased to welcome Dr. Deborah Cragun as this year's Anne Krush Lecturer! A leading researcher in hereditary cancer and genomic medicine, Dr. Cragun will present “The Science of Doing: Implementation Strategies for Cancer Genetics,” exploring approaches to integrating evidence-based genetic and genomic services into routine healthcare. 📅 Wednesday, November 4 | 8:15–9:00 AM 🔗 Learn more about Dr. Cragun ahead of the meeting: bit.ly/4si4pAc

Access to hereditary cancer genetic testing and precision medicine is not equal for everyone. Addressing these disparities is essential to making cancer prevention and care more equitable. At #CGAIGC26, Dr. Emily Mrig, Andrea Stoddard, Katherine Bonini, and Paula Chambers Raney will bring perspectives from research, clinical practice, genomics, and patient advocacy to Session V: Health Equity. Together, they'll explore barriers to cancer genetics services, strategies for expanding access to genetic testing, the role of emerging genomic technologies in health equity, and the importance of patient voices in improving cancer care. 📅 November 3 | 10:50 AM–12:10 PM 🔗 Meet the experts and advocates leading this discussion: Dr. Emily Mrig: bit.ly/4BgSDKr Katherine Bonini: bit.ly/4yyrJuW Paula Chambers: bit.ly/4i6cR0x

Next in our #CGAIGC26 invited speaker spotlight is Dr. Wendy Chung, who will deliver this year's Bert Vogelstein Lecture on November 3! 🎤 What happens when insights from genetic testing become actionable information for patients and their families? In her lecture, Dr. Chung will explore the role of genomic information in understanding health risks and informing clinical care. A renowned clinical and molecular geneticist, Dr. Chung has identified the genetic basis of more than 60 rare diseases and leads research aimed at advancing genetic screening and personalized medicine. 🔗 Get to know Dr. Chung ahead of the meeting: bit.ly/4sboUOP

🎙️ Our new APP podcast is here! Hear Heather Hannon, Carrie Thompson & Margaret Hornung explore career pathways, teamwork & hereditary cancer care. 🎧👉🔗cgaigc.com/podcast/episode/f… 🏔️ Continue the conversation at #CGAIGC26 in Denver, CO on Nov 2, 3:40 PM MT with the “How We Do It” presentation on "Defining, Expanding, Adapting Advanced Practice Provider Roles in Hereditary Cancer Care: Models, Challenges, and Real-World Practice." 📍👉🔗Visit cgaigcmeeting.org/ 🗓️Episode 2 arrives in November during National Nurse Practitioners Week, exploring APPs in practice and the future of hereditary GI cancer care. Stay tuned! @josiebakerGC #HereditaryGICancer

🌎 This #HispanicHeritageMonth, discover organizations offering genetic counseling & hereditary cancer resources across Latin America. Explore hereditary cancer resources from @SplaGen , @geth_org & SOCHIAGO across Latin America. 👏 Thanks, @ckurpad for this excellent blog highlighting these organizations & encouraging connections across borders. 📖 Read the blog: 👉🔗cgaigc.com/post/connecting-t… 📌 New Spanish-language content arrives tomorrow! #HereditaryGICancer #HereditaryCancer

Some of the most challenging questions in hereditary GI cancer care don't always have clear-cut answers. At #CGAIGC26, Dr. Peter Stanich and Dr. Zack Foda will go head-to-head in our returning Debate Session, “Oligopolyposis: Debating the Gray Zone,” exploring the complexities of clinical decision-making in this area. The session will also feature Dr. Giulia Martina Cavestro, who will share key outcomes from the Florence International Consensus on Idiopathic Adenomatous Polyposis (IAP) and their implications for clinical practice. 📅 November 2 | 9:00–9:55 AM 🔗 Get to know our speakers ahead of the meeting: Dr. Peter Stanich: bit.ly/4eiz5v9 Dr. Zack Foda: bit.ly/4AVm8RI Dr. Giulia Martina Cavestro: bit.ly/4hDMIaH

We're kicking off our introduction to the invited speakers at #CGAIGC26! 🎤 First up is Dr. James Ford, who will deliver this year's Randall Burt Lecture on November 2. How early can we identify the changes that lead to colorectal cancer, and what could this mean for prevention? Dr. Ford will explore how advanced multiomic profiling of familial adenomatous polyposis (FAP) is uncovering the earliest molecular and cellular changes in colorectal cancer development and revealing new opportunities for prevention. 🔗 Get to know Dr. Ford ahead of the meeting: bit.ly/4y6PzgY